<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01026350</url>
  </required_header>
  <id_info>
    <org_study_id>4811344-HMO-CTIL</org_study_id>
    <nct_id>NCT01026350</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Oral Colostrum Derived Anti Influenza Antibodies in Healthy Volunteers</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      Administration of colostrum enriched with anti-Flu antibodies may alter host's response to
      the flu virus.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>alterations in immune response to flu antigen</measure>
    <time_frame>during and after administration of colostrum enriched with anti flu antibodies</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Influenza</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>colostrum enriched with anti flu antibodies</intervention_name>
    <description>each volunteer will receive six 1.2 g oral tablets (equivalent to 600 mg of bovine colostrum powder each) once a day for two weeks.</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male volunteers ages 18-60

          -  If participating in sexual activity that could lead to pregnancy, the study volunteer
             must agree that two reliable methods of contraception will be used simultaneously
             while receiving the protocol-specified medication and for 1 month after stopping the
             medication

          -  Men &gt; 18 years.

          -  Ability and willingness of subject to provide informed consent

          -  Screening tests' results within 15% of normal values

        Exclusion Criteria:

          -  Female

          -  Continuous use of the following medications for more than 3 days within 30 days of
             study entry:

          -  Immunosuppressives

          -  Immune modulators

          -  Systemic glucocorticoids

          -  Anti-neoplastic agents

          -  Active drug or alcohol use or dependence that, in the opinion of the site
             investigator, would interfere with adherence to study requirements.

          -  Serious illness requiring systemic treatment and/or hospitalization within 30 days
             prior to entry.

          -  Subjects with a clinically significant infectious, immune mediated or malignant
             disease

          -  Subjects with anemia (Hb &lt;10.5 gm/dl)

          -  Subjects with thrombocytopenia (platelets &lt;100K/Âµl)

          -  Subjects with lymphopenia (absolute lymphocyte count &lt;0.7)

          -  Subjects who were previously vaccinated against flu.

          -  Subject who received any vaccination within the last 6 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>tomer adar, MD</last_name>
    <phone>972-2-6778511</phone>
    <email>tomerad@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>POB 12000</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>tomer adar, md</last_name>
      <phone>972-2-6778511</phone>
      <email>tomerad@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Tomer Adar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gadi Lalazar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mizrahi Mair, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuval Horowitz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Kim JH, Jung WS, Choi NJ, Kim DO, Shin DH, Kim YJ. Health-promoting effects of bovine colostrum in Type 2 diabetic patients can reduce blood glucose, cholesterol, triglyceride and ketones. J Nutr Biochem. 2009 Apr;20(4):298-303. doi: 10.1016/j.jnutbio.2008.04.002. Epub 2008 Jul 7.</citation>
    <PMID>18602824</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2009</study_first_submitted>
  <study_first_submitted_qc>December 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2009</study_first_posted>
  <last_update_submitted>December 3, 2009</last_update_submitted>
  <last_update_submitted_qc>December 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Immuron Limited</name_title>
    <organization>Immuron Limited</organization>
  </responsible_party>
  <keyword>modulating immune response to flu antigen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

